SCHEMBL24200438

SCHEMBL24200438

COc1ccc2c(c1)c1ncnc(Cl)c1n2C(O)c1ccccc1

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.46
ALDH1A1 P00352 4/20 0.46
HPGD P15428 4/20 0.46
HTT P42858 2/20 0.46
HSD17B10 Q99714 2/20 0.46
LMNA P02545 2/20 0.46
RXFP1 Q9HBX9 2/20 0.46
GAA P10253 2/20 0.46
GLA P06280 2/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
POLB P06746 3/20 0.43
MAPT P10636 3/20 0.39
PLA2G2A P14555 3/20 0.39
CASR P41180 1/20 0.38
AURKA O14965 1/20 0.37
RPS6KB1 P23443 1/20 0.37
KMT2A Q03164 2/20 0.37
PLA2G4A P47712 1/20 0.37
PDE4B Q07343 2/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20158911 0.77 KMT2A (0.54) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL20158977 0.77 KDM4E (0.68) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL20158976 0.77 LMNA (0.52) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL20138952 0.70 KMT2A (0.53) KDM4EALDH1A1HPGDHTTTSHR
SCHEMBL20159028 0.67 KDM4E (0.54) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL24200430 0.66 KDM4E (0.70) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL21341228 0.64 KDM4E (0.45) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL24969968 0.64 MEN1 (0.47) KDM4EALDH1A1LMNATSHRMAPK1
SCHEMBL20147149 0.64 MAOA (0.46) KDM4EALDH1A1HPGDHTTHSD17B10
SCHEMBL20147143 0.62 DYRK1A (0.41) KDM4EALDH1A1HPGDHTTHSD17B10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3538529-B1 SELECTIVE INHIBITORS OF GENOTOXIC STRESS-INDUCED IKK/NF-KB PATHWAYS MAX DELBRUECK CENTRUM FUER MOLEKULARE MEDIZIN HELMHOLTZ GEMEINSCHAFT (DE) 2022-01-19 EP disclosed